Subscribe to RSS
DOI: 10.1055/s-0044-1787673
Delayed Wound Healing Resulting from Inflammatory Process in Craniectomy Patients Treated with BioGlue: A Case Series with Literature Review
Abstract
Background BioGlue is touted as a safe and effective sealant for various surgical procedures. This article describes five cases of delayed wound healing associated with the use of BioGlue after craniectomies.
Case Description Five patients of different genders and ages who had undergone craniectomy with BioGlue were presented to our medical center with wound dehiscence and purulent discharge. The first attempt to solve this problem by incision and drainage was unsuccessful. The removal of BioGlue is necessary to eliminate these problems.
Discussion The presence of wound dehiscence and aseptic cystic contents may indicate a chronic inflammatory process following the application of BioGlue. This problem usually occurs within a few months after wound closure. For rapid intervention, it is recommended to perform an incision and drainage and remove the BioGlue. The main risk factor is directly applying BioGlue to the skin, subcutaneous tissue, or titanium material.
Conclusion Neurosurgeons should exercise caution and be aware of a possible delayed chronic inflammatory process in surgical wounds associated with the use of BioGlue as a sealant, especially when the product is used without cranial coverage or in cases where it comes into direct contact with subcutaneous tissue or titanium material. To resolve this issue quickly, BioGlue should be completely removed at the first attempt at incision and drainage.
Ethical Approval
This case series is registered by the hospital's Ethics Committee (number 133/2566) and it was carried out following the principles of the Helsinki Declaration.
Publication History
Article published online:
07 June 2024
© 2024. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Agha RA, Franchi T, Sohrabi C, Mathew G, Kerwan A. SCARE Group. The SCARE 2020 guideline: updating consensus surgical CAse REport (SCARE) guidelines. Int J Surg 2020; 84: 226-230
- 2 Mathew G, Sohrabi C, Franchi T, Nicola M, Kerwan A, Agha R. PROCESS Group. Preferred reporting of case series in surgery (PROCESS) 2023 guidelines. Int J Surg 2023; 109 (12) 3760-3769
- 3 Iino K, Yamamoto Y, Ueda H, Takemura H. Two-patch technique with BioGlue for ventricular septal rupture resulting from acute anterior myocardial infarction. JTCVS Tech 2022; 13 (13) 83-86
- 4 Sidle DM, Loos BM, Ramirez AL, Kabaker SS, Maas CS. Use of BioGlue surgical adhesive for brow fixation in endoscopic browplasty. Arch Facial Plast Surg 2005; 7 (06) 393-397
- 5 Rathinam S, Naidu BV, Nanjaiah P, Loubani M, Kalkat MS, Rajesh PB. BioGlue and Peri-strips in lung volume reduction surgery: pilot randomised controlled trial. J Cardiothorac Surg 2009; 4 (04) 37
- 6 Pasic M, Unbehaun A, Drews T, Hetzer R. Late wound healing problems after use of BioGlue for apical hemostasis during transapical aortic valve implantation. Interact Cardiovasc Thorac Surg 2011; 13 (05) 532-534
- 7 Babin-Ebell J, Bougioukakis P, Urbanski P, Froehner S, Diegeler A. Foreign material reaction to BioGlue® as a possible cause of cardiac tamponade. Thorac Cardiovasc Surg 2010; 58 (08) 489-491
- 8 Luthra S, Theodore S, Tatoulis J. Bioglue: a word of caution. Ann Thorac Surg 2008; 86 (03) 1055-1056 , author reply 1056–1057
- 9 Subasi B, Guclu E. The effects of using Bioglue in nasal septal surgery. Ear Nose Throat J 2021; 100 (07) 516-521
- 10 Singh A, Wyatt M, Clarke M, Wales L. Late sterile abscess formation in carotid endarterectomy following use of BioGlue: a word of caution. EJVES Short Rep 2017; 37 (37) 12-13
- 11 Singh A, Wales L. Late sterile cyst formation following use of Bioglue in carotid endarterectomy. EJVES 2019; 58 (06) e128
- 12 Kumar A, Maartens NF, Kaye AH. Evaluation of the use of BioGlue in neurosurgical procedures. J Clin Neurosci 2003; 10 (06) 661-664
- 13 Dusick JR, Mattozo CA, Esposito F, Kelly DF. BioGlue for prevention of postoperative cerebrospinal fluid leaks in transsphenoidal surgery: a case series. Surg Neurol 2006; 66 (04) 371-376
- 14 Gaberel T, Borgey F, Thibon P, Lesteven C, Lecoutour X, Emery E. Surgical site infection associated with the use of bovine serum albumine-glutaraldehyde surgical adhesive (BioGlue) in cranial surgery: a case-control study. Acta Neurochir (Wien) 2011; 153 (01) 156-162
- 15 Abuzayed B, Erman H, Inan M, Aydin S, Sanus GZ. Acute mass formation of Bioglue after spinal dural repair: a Glue-oma case report. Neurosurg Q 2010; 20 (04) 253-255
- 16 Qiu L, Qi See AA, Steele TWJ, Kam King NK. Bioadhesives in neurosurgery: a review. J Neurosurg 2019; 133 (06) 1928-1938
- 17 Yuen T, Kaye AH. Persistence of Bioglue in spinal dural repair. J Clin Neurosci 2005; 12 (01) 100-101